Hangethe Consulting AB

Track

Insider profile

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hangethe Consulting AB's trades of NextCell Pharma AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
436.56
Quantity 51,648
Value SEK3,600,573
Transaction date
Purchase
Price
424.80
Quantity 59,669
Value SEK1,776,621
Transaction date
Purchase
Price
418.40
Quantity 52,818
Value SEK3,956,079
Transaction date
Purchase
Price
0.03
Quantity 715,000
Value SEK19,794
Transaction date
Purchase
Price
3.95
Quantity 2,500
Value SEK9,875
Transaction date
Purchase
Price
3.85
Quantity 5,000
Value SEK19,250
Transaction date
Purchase
Price
3.90
Quantity 7,900
Value SEK30,810
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-14
B Purchase
51,648
436.56
SEK3,600,573 		51,648 436.56 SEK3,600,573
2024-06-18 2024-06-14
B Purchase
59,669
424.80
SEK1,776,621 		59,669 424.80 SEK1,776,621
2024-06-12 2024-06-11
B Purchase
52,818
418.40
SEK3,956,079 		52,818 418.40 SEK3,956,079
2024-06-11 2024-06-11
B Purchase
715,000
0.03
SEK19,794 		715,000 0.03 SEK19,794
2023-08-24 2023-08-24
B Purchase
2,500
3.95
SEK9,875 		2,500 3.95 SEK9,875
2023-08-24 2023-08-24
B Purchase
5,000
3.85
SEK19,250 		5,000 3.85 SEK19,250
2023-08-24 2023-08-24
B Purchase
7,900
3.90
SEK30,810 		7,900 3.90 SEK30,810